Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Seattle, WA
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Tacoma, WA
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated:  1/7/2016
mi
from
Camperdown,
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects
Status: Enrolling
Updated: 1/7/2016
mi
from
Camperdown,
Click here to add this to my saved trials
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Status: Enrolling
Updated:  1/7/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/7/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
The Use of Calcium and Magnesium for Prevention of Ixabepilone Induced Peripheral Neuropathy: A Phase III Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  1/7/2016
The Mayo Clinic
mi
from
Rochester, MN
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
The Use of Calcium and Magnesium for Prevention of Ixabepilone Induced Peripheral Neuropathy: A Phase III Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 1/7/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Pilot Study for Automated Deep Brain Stimulation Programming
DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I
Status: Enrolling
Updated:  1/8/2016
University of Cincinnati Department of Neurology
mi
from
Cincinnati, OH
Pilot Study for Automated Deep Brain Stimulation Programming
DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I
Status: Enrolling
Updated: 1/8/2016
University of Cincinnati Department of Neurology
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
Status: Enrolling
Updated:  1/11/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
Status: Enrolling
Updated: 1/11/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital Colorado
mi
from
Aurora, CO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Johns Hopkins University
mi
from
Baltimore, MD
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Harvard University, Boston Children's Hospital
mi
from
Boston, MA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Harvard University, Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Michigan
mi
from
Ann Arbor, MI
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Columbia-Presbyterian
mi
from
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Columbia-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
mi
from
Cincinnati, OH
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Medical Center of Dallas
mi
from
Dallas, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Baylor College of Medicine
mi
from
Houston, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Univ of Washington
mi
from
Seattle, WA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Mount Sinai Hosp
mi
from
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Hospital for Sick Children
mi
from
Toronto,
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Tolerance Following Peanut Oral Immunotherapy
Clinical Desensitization and Tolerance Following Peanut Oral Immunotherapy and Subsequent Allergen Avoidance
Status: Enrolling
Updated:  1/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Tolerance Following Peanut Oral Immunotherapy
Clinical Desensitization and Tolerance Following Peanut Oral Immunotherapy and Subsequent Allergen Avoidance
Status: Enrolling
Updated: 1/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
Status: Enrolling
Updated:  1/12/2016
Texas Children's Hospital
mi
from
Houston, TX
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
Status: Enrolling
Updated: 1/12/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  1/12/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 1/12/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated:  1/12/2016
The Ohio State University School of Medicine
mi
from
Columbus, OH
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated: 1/12/2016
The Ohio State University School of Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated:  1/12/2016
Baylor College of Medicine
mi
from
Houston, TX
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated: 1/12/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated:  1/12/2016
M.D. Anderson Cancer Center; Transplant site, please contact Baylor College of Medicine
mi
from
Houston, TX
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated: 1/12/2016
M.D. Anderson Cancer Center; Transplant site, please contact Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated:  1/12/2016
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis
Status: Enrolling
Updated: 1/12/2016
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Power Mobility on Young Children With Severe Motor Impairments
Effects of Power Mobility on the Development and Function of Young Children With Severe Motor Impairments
Status: Enrolling
Updated:  1/13/2016
Department of Rehabilitation Sciences, Lee Mitchener Tolbert Center for Develompental Disabilities
mi
from
Oklahoma City, OK
Effects of Power Mobility on Young Children With Severe Motor Impairments
Effects of Power Mobility on the Development and Function of Young Children With Severe Motor Impairments
Status: Enrolling
Updated: 1/13/2016
Department of Rehabilitation Sciences, Lee Mitchener Tolbert Center for Develompental Disabilities
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Consistency of Automated Neuropsychological Assessment Metrics (ANAM) Performance in Those With Deployment Acquired Mild Traumatic Brain Injury (TBI)
Consistency of ANAM Performance in Those With Deployment Acquired Mild TBI
Status: Enrolling
Updated:  1/13/2016
Eastern Colorado Health Sciences Denver VA MIRECC
mi
from
Denver, CO
Consistency of Automated Neuropsychological Assessment Metrics (ANAM) Performance in Those With Deployment Acquired Mild Traumatic Brain Injury (TBI)
Consistency of ANAM Performance in Those With Deployment Acquired Mild TBI
Status: Enrolling
Updated: 1/13/2016
Eastern Colorado Health Sciences Denver VA MIRECC
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001184
mi
from
Downey, CA
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001184
mi
from
Downey, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001017
mi
from
Fountain Valley, CA
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001017
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001037
mi
from
Augusta, GA
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001037
mi
from
Augusta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001186
mi
from
Chicago, IL
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001186
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site # 001110
mi
from
Overland Park, KA
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site # 001110
mi
from
Overland Park, KA
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001198
mi
from
Stratford, NJ
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001198
mi
from
Stratford, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001240
mi
from
Chapel Hill, NC
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001240
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001009
mi
from
Winston-Salem, NC
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001009
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001241
mi
from
Philadelphia, PA
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001241
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001211
mi
from
Pittsburgh, PA
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001211
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001245
mi
from
Chattanooga, TN
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001245
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #001226
mi
from
Houston, TX
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #001226
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site # 001197
mi
from
Miami, FL
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site # 001197
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated:  1/13/2016
Merz Investigational Site #420046
mi
from
Brno,
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb
Status: Enrolling
Updated: 1/13/2016
Merz Investigational Site #420046
mi
from
Brno,
Click here to add this to my saved trials
Vaporized Cannabis and Spinal Cord Injury Pain
The Effect of Vaporized Cannabis on Neuropathic Pain in Spinal Cord Injury
Status: Enrolling
Updated:  1/13/2016
UC Davis CTSC Clinical Research Center , Sacramento VA Medical Center
mi
from
Mather, CA
Vaporized Cannabis and Spinal Cord Injury Pain
The Effect of Vaporized Cannabis on Neuropathic Pain in Spinal Cord Injury
Status: Enrolling
Updated: 1/13/2016
UC Davis CTSC Clinical Research Center , Sacramento VA Medical Center
mi
from
Mather, CA
Click here to add this to my saved trials